CD4 and cancer: Similar results have been detected on T cell subsets in other types of cancer, such as BTLA upregulation on peripheral CD4 + T cells in hepatocellular carcinoma or tumor antigen-specific CD8 + T cells from melanoma [15, 18, 27].